Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aclidinium vs Tiotropium in Moderate to Severe COPD
NCT01462929Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Nov 2011; status: completed.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01462929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462929.